This healthcare stock engaged in providing cancer care, tertiary care, infertility treatment, and diagnostic services across India and Africa, jumped 7 percent after KKR acquires a controlling stake in the company for $400 million (approx. Rs. 3467 crores)
Stock Price Movement:
With a market capitalization of Rs. 7,229.43 crores, the share of Healthcare Global Enterprises Limited has reached an intraday high of Rs. 535 per equity share, rising nearly around 7 percent from its previous day’s close price of Rs. 500. Since then, the stock has retreated and is currently trading at Rs. 529.05 per equity share.
What Happened:
KKR, a leading global investment firm, has acquired a controlling stake in HealthCare Global Enterprises (HCG) for $400 million (approx. Rs. 3467.2 crore). Through this transaction, KKR will become the largest shareholder, acquiring up to 54 percent of equity from CVC Asia V at a purchase price of Rs. 445 per equity share. Following SEBI regulations, KKR will launch an open offer to acquire additional shares, potentially increasing its stake to 77 percent.
Entities and Services:
The company specializes in cancer care with 25 centers across India, offering oncology and bone marrow transplants. HCG hospitals provide multispecialty tertiary care, including cardiac and neurosurgery. Milann focuses on fertility treatments like IVF and ICSI. Triesta Sciences offers advanced diagnostics, including genetic testing. Additional services include robotic surgery and CT scans for precise treatments.
Business Operation:
HealthCare Global Enterprises (HCG) is India’s largest oncology hospital chain, offering specialized cancer care across 19 cities and 10 states. It operates 25 centers, including 4 multispecialty hospitals and 6 daycare centers.
With a network of more than 400 oncologists, 98 operation theaters, and over 2,500 beds, HCG provides advanced treatments like robotic surgery, LINAC radiotherapy, and PET CT scans. HCG remains dedicated to excellence in cancer care, providing millions with advanced medical technology and expertise.
Recent quarter results:
Healthcare Global Enterprises Limited’s revenue has increased from Rs. 469.87 crore in Q3 FY24 to Rs. 558.57 crore in Q3 FY25, which has grown by 18.88 percent. The net profit has also grown by 125.95 percent from Rs. 3.43 crore in Q3 FY24 to Rs. 7.75 crore in Q3 FY25.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses
